Farther Finance Advisors, LLC Cytokinetics Inc Transaction History
Farther Finance Advisors, LLC
- $2.06 Trillion
- Q2 2024
A detailed history of Farther Finance Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,260 shares of CYTK stock, worth $66,528. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,260
Previous 1,236
1.94%
Holding current value
$66,528
Previous $90.3 Million
23.63%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$775 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$604 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$430 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$397 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$346 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.97B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...